Clinical Report: Co-infection of HIV and HCV Among Patients Under ART in Nigeria

Overview

This study assesses the prevalence of HIV/HCV co-infection among patients receiving antiretroviral treatment in Ilorin, Nigeria. It highlights the significant public health implications and the necessity for routine HCV screening in PLHIV.

Background

HIV/HCV co-infection presents a substantial public health challenge, leading to increased disease burden and treatment complications compared to mono-infections. The prevalence of co-infection varies significantly across regions, necessitating updated epidemiological data to inform public health strategies. Understanding the dynamics of co-infection is crucial for improving clinical outcomes and implementing effective screening and treatment protocols.

Data Highlights

No numerical data was provided in the source material.

Key Findings

• HIV/HCV co-infection prevalence varies significantly across Nigeria, with reported rates from 0% to 23.2% in different studies.
• Co-infected individuals experience higher rates of liver disease-related mortality compared to those with HCV mono-infection.
• HIV infection exacerbates liver damage progression in co-infected patients.
• Routine HCV screening is recommended for PLHIV to facilitate early detection and management.
• Adherence to national guidelines for HCV screening can prevent ART-related hepatotoxicity in co-infected patients.

Clinical Implications

Healthcare providers should prioritize routine HCV screening for all patients with HIV to mitigate the risks associated with co-infection. Implementing national guidelines on HCV screening can enhance patient management and improve clinical outcomes for PLHIV.

Conclusion

The study underscores the urgent need for updated epidemiological data on HIV/HCV co-infection in Nigeria and highlights the importance of adhering to screening guidelines to improve patient care.

References

1. Various Authors, Global hepatitis report 2024, WHO -- Action for access in low- and middle-income countries
2. Open Forum Infectious Diseases, 2021 -- People With HIV Are More Likely to Clear Hepatitis C: Role of Ryan White Services
3. Infection, 2020 -- Impact of COVID-19 on Individuals with HIV-1: Insights from a Northern Italy Medical Center
4. Open Forum Infectious Diseases, 2021 -- Assessment of the Hepatitis C Virus Clearance Pathway in Individuals Coinfected with HIV and HCV
5. Patients With HIV/HCV Coinfection – HCV Guidance, hcvguidelines.org -- HCV Guidance
6. Open Forum Infectious Diseases — HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative
7. Patients With HIV/HCV Coinfection – HCV Guidance
8. Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients - PMC
9. | Global hepatitis report 2024 Action for access in low- and middle-income countries None